Syndax Pharmaceuticals (SNDX) Earnings Date & Reports

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SNDX is expected to report earnings to rise 1.43% to -99 cents per share on August 11

Syndax Pharmaceuticals SNDX Stock Earnings Reports

Q2'25

Est.

$-0.99

Q1'25

Beat

by $0.26

Q4'24

Missed

by $0.26

Q3'24

Beat

by $0.09

Q2'24

Beat

by $0.11

The last earnings report on May 05 showed earnings per share of -98 cents, beating the estimate of -124 cents. With 3.90M shares outstanding, the current market capitalization sits at 930.17M.

View a ticker or compare two or three

Compare

SNDX